WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced entering into a Collaborative Research and Development Agreement with VivaCell Biotechnology España S.L., Cordoba, Spain to develop a combination therapy for the treatment of HIV latency.
